Alpha-Stim AID for managing anxiety disorders (MTG56)
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders
Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart
The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or...
NICE indicators. NM39 smoking cessation.
Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart
Everything NICE has said on neurological conditions in an interactive flowchart
Everything NICE has said on managing atopic eczema in children up to 12 years, and treating eczema in people aged 13 years and over, in an interactive flowchart
Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults
Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart
Evidence-based recommendations on free-functioning gracilis transfer to restore upper limb function in brachial plexus injury in adults. This involves a piece o
Evidence-based recommendations on baricitinib for treating moderate to severe atopic dermatitis in adults
Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple
This guideline sets out an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations are for adults, young people and children aged 72 hours and over. They do not cover diagnosis.
The percentage of patients aged 79 years or under with coronary heart disease in whom the last blood pressure reading (measured in the preceding 12...
This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Everything NICE has said on psoriasis in an interactive flowchart
Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart
Everything NICE has said on assessing and treating people with fertility problems in an interactive flowchart
Everything NICE has said on the care of healthy women and their babies during childbirth in an interactive flowchart
Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart
Everything NICE has said on contraceptive services for under 25s in an interactive flowchart
Everything NICE has said on perioperative care in adults in an interactive flowchart.
Everything NICE has said on diagnosing and managing suspected idiopathic pulmonary fibrosis in adults in an interactive flowchart
Everything NICE has said on diagnosing and managing metastatic malignant disease of unknown primary origin in an interactive flowchart
Everything NICE has said on antimicrobial prescribing for cellulitis and erysipelas in an interactive flowchart
Everything NICE has said on assessing and managing familial breast cancer and related risks in people with a family history in an interactive flowchart
Everything NICE has said on low back pain and sciatica in an interactive flowchart
Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart
Everything NICE has said on safeguarding adults in care homes in an interactive flowchart.
This guideline covers keeping adults in care homes safe from abuse and neglect. It includes potential indicators of abuse and neglect by individuals or organisations, and covers the safeguarding process from when a concern is first identified through to section 42 safeguarding enquiries. There are recommendations on policy, training, and care home culture, to improve care home staff awareness of safeguarding and ensure people can report concerns when needed.
Everything NICE has said on endocrine, nutritional and metabolic conditions in an interactive flowchart
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
Evidence-based recommendations on filgotinib (Jyseleca) for moderate to severe rheumatoid arthritis in adults
NICE is unable to make a recommendation on omalizumab (Xolair) for treating chronic rhinosinusitis with nasal polyps in adults because Novartis Pharmaceuticals
Everything NICE has said on ear, nose and throat conditions in an interactive flowchart
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
Evidence-based recommendations on dapagliflozin (Forxiga) for symptomatic chronic heart failure with reduced ejection fraction in adults
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults
Evidence-based recommendations on autologous anti-CD19-transduced CD3+ cells for treating relapsed or refractory mantle cell lymphoma in adults who have
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
Everything NICE has said on managing faecal incontinence in adults in an interactive flowchart
In those patients with a new diagnosis of hypertension or type 2 diabetes aged 25-84 years, recorded between the preceding 1 April to 31 March...
Evidence-based recommendations on niraparib for maintenance treatment of advanced (FIGO stages 3 and 4) high-grade epithelial ovarian, fallopian tube or primary
NICE is unable to make a recommendation on pembrolizumab (Keytruda) for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when
NICE is unable to make a recommendation on vernakalant (Brinavess) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. This
Everything NICE has said on bladder cancer in adults in an interactive flowchart
Everything NICE has said on improving the experience of care for people using adult NHS mental health services in an interactive flowchart